142 related articles for article (PubMed ID: 31369531)
1. Economic burden of eczema in a middle-income country: A public hospital-based retrospective study in 2016-2017 in Vietnam.
Pham LD; Vo TQ; Hong Tran DT; My Ha NC; Nguyen VT; Vo NX
J Pak Med Assoc; 2019 Jun; 69(Suppl 2)(6):S28-S33. PubMed ID: 31369531
[TBL] [Abstract][Full Text] [Related]
2. Economic burden and productivity loss related to eczema: A prevalence-based follow-up study in Vietnam.
Le PH; Vo TQ
J Pak Med Assoc; 2019 Jun; 69(Suppl 2)(6):S57-S63. PubMed ID: 31369535
[TBL] [Abstract][Full Text] [Related]
3. A cost-utility analysis of pimecrolimus vs. topical corticosteroids and emollients for the treatment of mild and moderate atopic eczema.
Pitt M; Garside R; Stein K
Br J Dermatol; 2006 Jun; 154(6):1137-46. PubMed ID: 16704646
[TBL] [Abstract][Full Text] [Related]
4. The effectiveness and cost-effectiveness of pimecrolimus and tacrolimus for atopic eczema: a systematic review and economic evaluation.
Garside R; Stein K; Castelnuovo E; Pitt M; Ashcroft D; Dimmock P; Payne L
Health Technol Assess; 2005 Jul; 9(29):iii, xi-xiii,1-230. PubMed ID: 16022804
[TBL] [Abstract][Full Text] [Related]
5. Cost and effectiveness of prescribing emollient therapy for atopic eczema in UK primary care in children and adults: a large retrospective analysis of the Clinical Practice Research Datalink.
Moncrieff G; Lied-Lied A; Nelson G; Holy CE; Weinstein R; Wei D; Rowe S
BMC Dermatol; 2018 Oct; 18(1):9. PubMed ID: 30373584
[TBL] [Abstract][Full Text] [Related]
6. Importance of out-of-pocket costs for adult patients with atopic dermatitis in France.
Launois R; Ezzedine K; Cabout E; Reguai Z; Merrhand S; Heas S; Seneschal J; Misery L; Taieb C
J Eur Acad Dermatol Venereol; 2019 Oct; 33(10):1921-1927. PubMed ID: 30887577
[TBL] [Abstract][Full Text] [Related]
7. Economic Evaluation of Dupilumab for Moderate-to-Severe Atopic Dermatitis: A Cost-Utility Analysis.
Zimmermann M; Rind D; Chapman R; Kumar V; Kahn S; Carlson J
J Drugs Dermatol; 2018 Jul; 17(7):750-756. PubMed ID: 30005097
[TBL] [Abstract][Full Text] [Related]
8. The economic impact of asthma treatment on patients, 2014-2017: The Vietnamese experience from a public hospital.
Le NQ; Tran TV; Minh Tran TT; Kieu Dang NT; Truong QK; Vo TQ
J Pak Med Assoc; 2019 Jun; 69(Suppl 2)(6):S2-S9. PubMed ID: 31369528
[TBL] [Abstract][Full Text] [Related]
9. [Cost-of-illness study in patients suffering from atopic eczema in Germany].
Ehlken B; Möhrenschlager M; Kugland B; Berger K; Quednau K; Ring J
Hautarzt; 2005 Dec; 56(12):1144-51. PubMed ID: 15933866
[TBL] [Abstract][Full Text] [Related]
10. Economic burden of cutaneous infections in children and adults with atopic dermatitis.
Sandhu JK; Salame N; Ehsani-Chimeh N; Armstrong AW
Pediatr Dermatol; 2019 May; 36(3):303-310. PubMed ID: 30968453
[TBL] [Abstract][Full Text] [Related]
11. Clinical and cost-effectiveness of once-daily versus more frequent use of same potency topical corticosteroids for atopic eczema: a systematic review and economic evaluation.
Green C; Colquitt JL; Kirby J; Davidson P; Payne E
Health Technol Assess; 2004 Nov; 8(47):iii,iv, 1-120. PubMed ID: 15527669
[TBL] [Abstract][Full Text] [Related]
12. The costs of atopy and asthma in children: assessment of direct costs and their determinants in a birth cohort.
Weinmann S; Kamtsiuris P; Henke KD; Wickman M; Jenner A; Wahn U
Pediatr Allergy Immunol; 2003 Feb; 14(1):18-26. PubMed ID: 12603707
[TBL] [Abstract][Full Text] [Related]
13. The economic burden attributable to asthmatic inpatients and outpatients in a military hospital, Vietnam: A retrospective 5-year analysis.
Vo TQ; Nguyen HM; Thai TH; La VN; Truong QK
J Pak Med Assoc; 2019 Jun; 69(Suppl 2)(6):S41-S48. PubMed ID: 31369533
[TBL] [Abstract][Full Text] [Related]
14. Adding emollient bath additives to standard eczema management for children with eczema: the BATHE RCT.
Santer M; Rumsby K; Ridd MJ; Francis NA; Stuart B; Chorozoglou M; Roberts A; Liddiard L; Nollett C; Hooper J; Prude M; Wood W; Thomas-Jones E; Becque T; Thomas KS; Williams HC; Little P
Health Technol Assess; 2018 Oct; 22(57):1-116. PubMed ID: 30362939
[TBL] [Abstract][Full Text] [Related]
15. The cost of atopic dermatitis in the Netherlands: an international comparison.
Verboom P; Hakkaart-Van L; Sturkenboom M; De Zeeuw R; Menke H; Rutten F
Br J Dermatol; 2002 Oct; 147(4):716-24. PubMed ID: 12366418
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and cost-effectiveness of daily all-over-body application of emollient during the first year of life for preventing atopic eczema in high-risk children (The BEEP trial): protocol for a randomised controlled trial.
Chalmers JR; Haines RH; Mitchell EJ; Thomas KS; Brown SJ; Ridd M; Lawton S; Simpson EL; Cork MJ; Sach TH; Bradshaw LE; Montgomery AA; Boyle RJ; Williams HC
Trials; 2017 Jul; 18(1):343. PubMed ID: 28732519
[TBL] [Abstract][Full Text] [Related]
17. Expert panel on practice patterns in the management of cow's milk protein allergy and associated economic burden of disease on health service in Turkey.
Sekerel BE; Seyhun O
J Med Econ; 2017 Sep; 20(9):923-930. PubMed ID: 28602101
[TBL] [Abstract][Full Text] [Related]
18. Improved emollient use reduces atopic eczema symptoms and is cost neutral in infants: before-and-after evaluation of a multifaceted educational support programme.
Mason JM; Carr J; Buckley C; Hewitt S; Berry P; Taylor J; Cork MJ
BMC Dermatol; 2013 May; 13():7. PubMed ID: 23679991
[TBL] [Abstract][Full Text] [Related]
19. Public Health Burden and Epidemiology of Atopic Dermatitis.
Silverberg JI
Dermatol Clin; 2017 Jul; 35(3):283-289. PubMed ID: 28577797
[TBL] [Abstract][Full Text] [Related]
20. [The annual cost of medical care for patients with moderate to severe atopic dermatitis in Mexico. A multicenter study].
Guevara-Sanginés E; Pérez-Rojas D; Nevárez-Sida A; Aceves MA; Barrón-Tapia MT; Abaroa-Cantú FJ; Ancona-Castro C; García-Salazar MR; Hernández-Rodríguez JM; García-Contreras F; Estrada-Aguilar L
Rev Alerg Mex; 2020; 67(1):9-18. PubMed ID: 32447863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
